Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- [F-18]FlorastaminPhase 32 trials
FutureChem · High Risk Prostate Carcinoma
- 1.0% IP-001IP-001Phase 32 trials
Immunophotonics, Inc. · Colorectal Cancer (CRC), Colon Cancer Liver Metastases, Rectal Cancer
- 177Lu-edotreotide PRRT177Lu-DOTATOC, 177Lu-EdoPhase 32 trials
ITM Solucin GmbH · Neuroendocrine Tumors
- 177Lu-NYM032Phase 32 trials
Norroy Bioscience Co., LTD · Prostate Cancer, Metastatic Castration-resistant Prostate Cancer
- 6-Thio-2'-Deoxyguanosine6-thio-dG, THIOPhase 32 trials
Maia Biotechnology · Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small -Cell Lung
- 7MW3711Phase 32 trials
Mabwell (Shanghai) Bioscience Co., Ltd. · Solid Tumor, Lung Squamous Cell Carcinoma
- A166Phase 32 trials
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Her 2 Positive Breast Cancer, HER2-positive Breast Cancer
- AAA817[225Ac]Ac-PSMA-617Phase 32 trials
Novartis · Prostate Cancer
- ABP 206Phase 32 trials
Amgen · Melanoma
- ABP 234Phase 32 trials
Amgen · Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC), Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
- anzutresgene autoleucelIMA203 Product, IMA203 product- flat dosePhase 32 trials
Immatics US, Inc. · Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult
- ARDTPhase 32 trials
Novartis · Metastatic Castration-Resistant Prostate Cancer (mCRPC), Prostatic Neoplasms
- ARPI: EnzalutamideARPI abirateronePhase 32 trials
Novartis · Metastatic Castration Resistant Prostate Cancer (mCRPC), Prostate Cancer
- ASKC202Phase 32 trials
Jiangsu Aosaikang Pharmaceutical Co., Ltd. · EGFR Activating Mutation, Non-Squamous Non-Small Cell Lung Cancer (NSCLC), MET Positive
- AST-001Phase 32 trials
Ascentawits Pharmaceuticals, Ltd · Solid Tumor, Pancreatic Cancer, Autism Spectrum Disorder
- ATG-022Phase 32 trials
Antengene Biologics Limited · Advanced Gastric or Gastroesophageal Junction Adenocarcinoma, Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- AU-011Bel-sarPhase 32 trials
Aura Biosciences · Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma
- BAT1308Recombinant humanized anti-PD-1 monoclonal antibodyPhase 32 trials
Bio-Thera Solutions · Cervical Cancer, Advanced Solid Tumors
- BCD-217Phase 32 trials
Biocad · Melanoma Stage III, Melanoma (Skin), Melanoma
- BefotertinibPhase 32 trials
Betta Pharmaceuticals Co., Ltd. · Non-Small Cell Lung Cancer, EGFR Sensitive Mutation, Adjuvant Therapy
- BL-8040Phase 32 trials
BioLineRx, Ltd. · Multiple Myeloma, Pancreatic Adenocarcinoma
- BL-M14D1Phase 32 trials
SystImmune Inc. · Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma
- BrenetafuspIMC-F106CPhase 32 trials
Immunocore Ltd · Select Advanced Solid Tumors, Advanced Melanoma
- CDK4Phase 32 trials
Qilu Pharmaceutical Co., Ltd. · Advanced ER+/HER2- Breast Cancer, Breast Cancer
- CF102NamodenosonPhase 32 trials
Can-Fite BioPharma · Pancreatic Adenocarcinoma, Pancreatic Cancer, Hepatocellular Carcinoma
- CMP 001VidutolimodPhase 32 trials
Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer
- CobolimabPhase 32 trials
GSK · Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma
- Copper Cu 64 PSMA I&TPhase 32 trials
Curium US LLC · Prostate Cancer, Prostate Adenocarcinoma, Biochemical Recurrence of Malignant Neoplasm of Prostate
- CRB-701Phase 32 trials
Corbus Pharmaceuticals Inc. · Solid Tumor, Adult, Oropharyngeal Carcinoma (OPC)
- CTXPhase 32 trials
Ascentage Pharma Group Inc. · CLL/SLL, Breast Cancer
- CTX-009Phase 32 trials
Compass Therapeutics · Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer
- DN022150Phase 32 trials
Jiangxi Kvvit Pharmaceutical Co., Ltd. · Pancreatic Cancer, Pancreatic Carcinoma
- EG-007Phase 32 trials
Evergreen Therapeutics, Inc. · Advanced Endometrial Cancer
- EmactuzumabPhase 32 trials
Roche (Genentech) · Cancer, TGCT
- EnlituoPhase 32 trials
Taizhou Mabtech Pharmaceutical Co.,Ltd · Colorectal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
- EU-sourced KeytrudaPhase 32 trials
Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer, Non Squamous Non Small Cell Lung Cancer
- EzabenlimabBI 754091Phase 32 trials
Boehringer Ingelheim · Advanced Cancer, Neoplasm Metastasis, Advanced Tumors
- FG-M108M108Phase 32 trials
FutureGen Biopharmaceutical (Beijing) Co., Ltd · Claudin 18.2, Solid Tumor Malignancies, Pancreatic Cancer
- FicerafuspPhase 32 trials
Bicara Therapeutics · Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
- GLS-010Phase 32 trials
Guangzhou Gloria Biosciences Co., Ltd. · Solid Tumor, Persistent, Recurrent, or Metastatic Cervical Cancer
- HLX87Phase 32 trials
Shanghai Henlius Biotech · HER2 + Breast Cancer
- HMPL-306Phase 32 trials
Hutchmed · Acute Myeloid Leukemia, Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation
- HMPL-453Phase 32 trials
Hutchmed · Advanced Intrahepatic Cholangiocarcinoma, Solid Tumor, Adult, Solid Tumor
- IBI310Phase 32 trials
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma
- Inactive controlQLS-111 vehiclePhase 32 trials
Can-Fite BioPharma · Hepatocellular Carcinoma, Cirrhosis, Open-angle Glaucoma (OAG)
- INCA33890Phase 32 trials
Incyte · CRC (Colorectal Cancer)
- IparomlimabPhase 32 trials
Qilu Pharmaceutical Co., Ltd. · Small-cell Lung Cancer, Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
- JAB-3312Phase 32 trials
Allist Pharmaceuticals, Inc. · KRAS P.G12C, Non-small Cell Lung Cancer, Colorectal Cancer
- JK-1201IPhase 32 trials
JenKem Technology Co., Ltd. · Glioblastoma Multiforme (GBM), Small Cell Lung Cancer
- JMT103NarlumosbartPhase 32 trials
Shanghai JMT-Bio Inc. · Giant Cell Tumor of Bone, Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.